Literature DB >> 9453471

Renal response to infusion of dopamine precursors in anaesthetized rats.

B Mühlbauer1, C H Gleiter, C Gies, G Luippold, P A Löschmann.   

Abstract

In the present study the renal response to intravenous infusion of the catecholamine precursors L-dihydroxyphenylalanine (L-DOPA) or L-tyrosine was investigated in thiopentone sodium-anaesthetized Sprague-Dawley rats. Glomerular filtration rate (GFR) was assessed by renal clearance of inulin, urinary concentration of dopamine (U(DA)V) by HPLC and sodium excretion (U(Na)V) by flame photometry. We found that basal U(DA)V was 6.5 +/- 0.5 pmol/min per 100 g body weight (mean +/- SEM). Intravenous infusion of L-tyrosine at 0. 1-3.0 micromol/min dose dependently enhanced U(DA)V (17 +/- 3 to 144 +/- 14 pmol/min respectively) with higher doses of L-tyrosine resulting in no further increase in U(DA)V. Compared with L-tyrosine administration significantly lower doses of L-DOPA (0.07 to 35 nmol/min) caused increases in U(DA)V which were orders of magnitude higher (18 +/- 1 to 7800 +/- 470 pmol/min, respectively) and did not show saturation characteristics. GFR did not change in response to L-tyrosine or L-DOPA infusion. No variations in urinary flow rate or in U(Na)V could be observed which were significantly correlated to changes in U(DA)V. In contrast, intravenous infusion of dopamine at a dose of 6 nmol/min significantly increased GFR by 35 +/- 6.2% and urinary flow rate by over 2-fold. Immunohistochemistry with light microscopy revealed no tyrosine hydroxylase in the kidney. Therefore, dopamine synthesis in the tubular cells mainly depends on the renal supply of L-DOPA. The unchanged GFR and U(Na)V in spite of large variations of U(DA)V argue against the hypothesis that intratubular dopamine plays a functional role in the regulation of hemodynamics or sodium transport in the kidney. Renal dopamine excretion may rather represent an effective pathway for the elimination of catecholamine precursors from the plasma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9453471     DOI: 10.1007/pl00005125

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  4 in total

1.  Absence of amino acid-induced glomerular hyperfiltration in dopamine D3 receptor knockout mice.

Authors:  Gerd Luippold; Bärbel Pech; Swetlana Schneider; Karla Drescher; Reinhold Müller; Gerhard Gross; Bernd Mühlbauer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-12-22       Impact factor: 3.000

2.  Pharmacological profile and toxicity of fluorescein-labelled sinistrin, a novel marker for GFR measurements.

Authors:  Johannes Pill; Oxana Issaeva; Stefanie Woderer; Maliha Sadick; Bettina Kränzlin; Fritz Fiedler; Hans-Martin Klötzer; Uwe Krämer; Norbert Gretz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-12       Impact factor: 3.000

3.  Dopamine is metabolised by different enzymes along the rat nephron.

Authors:  Fernando R Ibarra; Inés Armando; Susana Nowicki; Andrea Carranza; Verónica De Luca Sarobe; Elvira E Arrizurieta; Marta Barontini
Journal:  Pflugers Arch       Date:  2005-04-30       Impact factor: 3.657

4.  Both stimulatory and inhibitory effects of dietary 5-hydroxytryptophan and tyrosine are found on urinary excretion of serotonin and dopamine in a large human population.

Authors:  George J Trachte; Thomas Uncini; Marty Hinz
Journal:  Neuropsychiatr Dis Treat       Date:  2009-05-20       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.